| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0051 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |